As H-1B visa changes keep coming, biopharmas adjust hiring approach

The $100,000 H-1B visa fee has significantly affected who biopharma companies hire, according to two experts. It’s not the only program adjustment affecting foreign-born job seekers’ odds of working in the U.S.

Rhyter Times aggregates short excerpts. The full story is reported by Biospace.

Read the full story at Biospace →